SCHEMBL12831778

SCHEMBL12831778

CC1(S(=O)(=O)NC(=O)C2CC2)CC1

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 1/20 0.33
CDK9 P50750 1/20 0.33
POLB P06746 2/20 0.32
HTT P42858 2/20 0.32
NAMPT P43490 1/20 0.32
NR1H4 Q96RI1 1/20 0.31
KMT2A Q03164 1/20 0.31
NPC1 O15118 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
GLA P06280 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23105808 0.81 CCNT1 (0.33) CCNT1CDK9POLBKMT2ALMNA
SCHEMBL20629742 0.77 NPC1 (0.33) KMT2ANPC1HPGDSMN1; SMN2
SCHEMBL6864014 0.74 DHFR (0.31) SMN1; SMN2
SCHEMBL13729390 0.74 FFAR3 (0.35)
SCHEMBL15593749 0.73 NR1H4 (0.36) NR1H4KMT2ALMNA
SCHEMBL8140531 0.72 HDAC8 (0.31) HDAC8HDAC6GAA
SCHEMBL4110765 0.72 POLB (0.36) POLBHTTNAMPTKMT2AHDAC8
SCHEMBL8275843 0.71
SCHEMBL883038 0.71
SCHEMBL15828901 0.71 CA1 (0.31) NR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4545535-A1 THIENOPYRIMIDINE DERIVATIVES AS ACC INHIBITORS AND USES THEREOF Gilead Sciences, Inc. (US) 2025-04-30 EP disclosed
CN-114206884-B Thienopyrimidine derivatives as ACC inhibitors and use thereof 吉利德科学公司 2024-07-12 CN disclosed
CN-114206884-A Thienopyrimidine derivatives as ACC inhibitors and uses thereof 吉利德科学公司 2022-03-18 CN disclosed
WO-2011038293-A1 CYCLIC PEPTIDE INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2011-03-31 WO disclosed